Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
3,047
-322
-10% -$58.4K 0.16% 63
2026
Q1
$496K Buy
3,369
+176
+6% +$28.6K 0.21% 52
2025
Q4
$622K Sell
3,193
-156
-5% -$37.1K 0.23% 46
2025
Q3
$942K Buy
3,349
+1,196
+56% +$305K 0.42% 34
2025
Q2
$471K Sell
2,153
-16
-0.7% -$2.58K 0.21% 48
2025
Q1
$303K Sell
2,169
-16
-0.7% -$2.6K 0.15% 65
2024
Q4
$364K Sell
2,185
-315
-13% -$56K 0.17% 55
2024
Q3
$426K Buy
2,500
+20
+0.8% +$2.9K 0.25% 45
2024
Q2
$350K Buy
+2,480
New +$308K 0.24% 44

Other funds holding ORCL

FreeGulliver LLC's ORCL Position: Q2 2026 in Review

FreeGulliver LLC reduced its Oracle (ORCL) stake by 9.6% in Q2 2026, selling an estimated $58.4K and leaving 3,047 shares worth $447K. The position accounts for 0.16% of the portfolio, ranked #63.

FreeGulliver LLC first reported a position in ORCL in Q2 2024 and has held it in 9 quarters since. The position peaked at $942K in Q3 2025. 3,524 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • FreeGulliver LLC held 3,047 shares of Oracle worth $447K as of Q2 2026.
  • FreeGulliver LLC sold 322 Oracle shares in Q2 2026, an estimated $58.4K.
  • Oracle made up 0.16% of FreeGulliver LLC's portfolio in Q2 2026, its #63 holding.
  • FreeGulliver LLC first reported a position in Oracle in Q2 2024 and has held it in 9 quarters since.
  • FreeGulliver LLC's Oracle position peaked at $942K in Q3 2025.
  • 3,524 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on FreeGulliver LLC's 13F filing for Q2 2026, filed 11 Aug 2026.